State IN
Clinical Trials in Indiana
Recruiting clinical trials with at least one study location in Indiana. Data updated daily from ClinicalTrials.gov.
Top Conditions in Indiana
Frequently Asked Questions — Clinical Trials in Indiana
How many clinical trials are currently recruiting in Indiana?
ClinicalMetric currently tracks 169 actively recruiting clinical trials with at least one location in Indiana. The total number of registered studies—including active but not currently enrolling trials—is 169. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Indiana?
Indiana hosts clinical trials across a broad range of medical conditions, including Heart Failure, Amblyopia, Crohn's Disease, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Indiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Indiana?
To join a clinical trial in Indiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Indiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Indiana
NCT05987449 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics...
Condition
Hemophilia A
Enrollment
60 pts
Location
United States, Canada, Italy
Sponsor
Hoffmann-La Roche
NCT05929768 Phase 3
Recruiting
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple N...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
2,400 pts
Location
United States, Mexico, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT05465174 Phase 2
Recruiting
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
Condition
Craniopharyngioma, Child
Enrollment
57 pts
Location
United States, Australia
Sponsor
Sabine Mueller, MD, PhD
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
NCT06952660 Phase 4
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic C...
Condition
Cervical Cancer
Enrollment
100 pts
Location
United States, Puerto Rico
Sponsor
Pfizer
NCT07095452 Phase 2, Phase 3
Recruiting
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous...
Condition
Multiple Myeloma
Enrollment
660 pts
Location
United States, France, Japan
Sponsor
AbbVie
NCT06498960 N/A
Recruiting
Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in No...
Condition
Normal Pressure Hydrocephalus
Enrollment
230 pts
Location
United States, Argentina, Canada
Sponsor
CereVasc Inc
NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
NCT07455136 N/A
Recruiting
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Trau...
Condition
Traumatic Brain Injury
Enrollment
2,000 pts
Location
United States
Sponsor
Hoffmann-La Roche
NCT04729114 Phase 1
Recruiting
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Ca...
Condition
Prostate Cancer
Enrollment
174 pts
Location
United States, Puerto Rico
Sponsor
Astellas Pharma Global Develop
NCT06784999 Phase 4
Recruiting
Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Followi...
Condition
Free Flap Reconstruction
Enrollment
128 pts
Location
United States
Sponsor
Indiana University
NCT00064870 N/A
Recruiting
Alzheimer's Disease Genetics Study
Condition
Alzheimer Disease
Enrollment
10,000 pts
Location
United States
Sponsor
Indiana University
NCT05285553 N/A
Recruiting
MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms
Condition
Myopia
Enrollment
900 pts
Location
United States
Sponsor
CooperVision, Inc.
NCT07553637 Phase 2
Recruiting
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Condition
Treatment-resistant Depression (TRD)
Enrollment
178 pts
Location
United States, United Kingdom
Sponsor
Alto Neuroscience
NCT05821309 Phase 4
Recruiting
Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placemen...
Condition
Constipation
Enrollment
65 pts
Location
United States
Sponsor
Indiana University
NCT06589804 Phase 3
Recruiting
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatme...
Condition
Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment
158 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05656365 N/A
Recruiting
Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, P...
Condition
Periodic Fever, Aphthous Stomatitis, Pharyngitis, And Cervical Adenitis (Pfapa)
Enrollment
1,500 pts
Location
United States
Sponsor
National Institute of Allergy
NCT05064709 N/A
Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Condition
Heart Failure
Enrollment
1,500 pts
Location
United States
Sponsor
Impulse Dynamics
NCT04862221 Phase 2
Recruiting
TReatment for ImmUne Mediated PathopHysiology
Condition
Acute Liver Failure
Enrollment
163 pts
Location
United States
Sponsor
National Institute of Diabetes
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT03838926 Phase 1
Recruiting
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hem...
Condition
Relapsed or Refractory Hematologic Malignancies
Enrollment
42 pts
Location
United States, Poland
Sponsor
Vanda Pharmaceuticals
NCT06586515 Phase 1
Recruiting
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tum...
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
630 pts
Location
United States, Canada, China
Sponsor
Eli Lilly and Company
NCT04657068 Phase 1, Phase 2
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Condition
Advanced Cancer
Enrollment
442 pts
Location
United States, France, Spain
Sponsor
Artios Pharma Ltd
NCT05183035 Phase 3
Recruiting
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Condition
Acute Myeloid Leukemia
Enrollment
130 pts
Location
United States, Australia, Austria
Sponsor
PedAL BCU, LLC
NCT06948214 Phase 3
Recruiting
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Condition
Growth Hormone Deficiency (GHD)
Enrollment
150 pts
Location
United States, Australia, New Zealand
Sponsor
Lumos Pharma
Page 1 of 7 — 169 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology